Adhera Therapeutics Inc (ATRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ATRX Annual Balance Sheets →
The table below presents a historical view of Adhera Therapeutics Inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2023)
(Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Assets
Cash & cash equivalent0.06
Cash & Short-term Investments0.00
Prepaid Expense, Current AS0.02
Total Current Assets0.08
Total Assets0.08
Liabilities
Accounts Payable, Current AC2.32
Accrued Liabilities, Current AC5.14
Derivative Liability, Current DE4.25
Loans Payable, Current NO9.42
Other Liabilities, Current1.74
Total Current Liabilities22.87
Total Long-term Debt0.00
Total Liabilities22.87
Stockholders' Equity
Common Stock Value0.02
Treasury Stock Value0.00
Additional Paid In Capital Common Stock33.61
Retained Earnings / Accumulated Deficit-56.42
Other Equity0.00
Common Stockholder's Equity-22.79
Total Stockholder's Equity-22.79
Liabilities & Stockholder's Equity0.08
4 historic quarters locked

Sign in to unlock the full Adhera Therapeutics Inc balance sheet history.

About Adhera Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-23-042138

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.